Treatment with immunotherapy alone produces ‘exceptional’ response rates in some melanoma patients
COLUMBUS, Ohio – Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded ...
COLUMBUS, Ohio – Data from a national clinical trial shows that a striking 89% of patients with desmoplastic melanoma responded ...
VIDEO OF RESEARCHER AND PATIENT COMMENTARY IS AVAILABLE AT: https://bcove.video/3mxxASq The combination of an experimental mRNA vaccine with an ...
ICB therapy, which stands for Immune Checkpoint Blockade, has become the standard treatment for lung cancer due to its generally ...
Glioblastomas (GBM) are the most aggressive and deadly kind of brain tumors, with less than 7% of patients surviving to ...
Research led by scientists at UCLA Jonsson Comprehensive Cancer Center found that responses to a type of immunotherapy called PD-1 checkpoint blockade ...
FOR IMMEDIATE RELEASE A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer ...
In mice with melanoma, probiotic bacteria travel from the gut and establish in tumors, where they directly stimulate immune cells ...
The number of immune cells in and around kidney tumors, the amount of dead cancer tissue, and mutations to a ...
Tuesday, 4 April 2023: An international panel of oncology and immunotherapy experts led by RCSI’s Professor Jarushka Naidoo, has developed ...
Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade ...
Study Title: Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, ...
MARCH 30, 2023, NEW YORK – Two independent Ludwig Cancer Research studies published in the current issue of the journal ...
HOUSTON ― A novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous (IV) immunotherapy was ...
Credit: VHIO. Non-canonical proteins are unconventional protein products that are not part of the known protein-coding genome repertoire. They ...
Media contacts: Robin Marks, 628-399-0370 Robin.Marks@ucsf.edu | @UCSF Julie Langelier, 415-734-5000 julie.langelier@gladstone.org | @GladstoneInst New Data Show Therapies May Activate Lymph Nodes to Produce ...
Alexandria, VA – A symposium aiming to provide a better understanding of the tumor microenvironment, immune tolerogenic niches at cancer initiation, ...
HOUSTON ― In a Phase II trial led by researchers from The University of Texas MD Anderson Cancer Center, adding ...
Although chimeric antigen receptor (CAR) T cell therapy has shown potential in the treatment of hematological malignancies, its application in solid tumors ...
BOSTON – A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types ...
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health have ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.